Gamelin Erick

Chief Development Officer at ACRV

Sold, on record
$1k
Dollars the filings state
Form 4 sales
2
Latest Nov 17, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • ACRVAcrivon Therapeutics, Inc.Chief Development Officer

Sales by reason

0
Routine
0
Plan not stated
2
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale ACRVNo plan
    Aug 18 2026

    Sold 400 shares at $2.01 ($804)

    Gamelin Erick, Chief Development Officer

    No 10b5-1 planSold 0.8% of holdings ($107k position)52,592 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale ACRVNo plan
    Nov 17 +91 days

    Sold 416 shares at $1.45 ($603)

    Gamelin Erick, Chief Development Officer

    No 10b5-1 planSold 0.8% of holdings ($76k position)52,176 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Gamelin Erick
Source
Nov 17, 2026ACRVChief Development OfficerForm 4 sale416$6030.8%No planSEC
Aug 18, 2026ACRVChief Development OfficerForm 4 sale400$8040.8%No planSEC